November 26, 2019
Alpha Tau Medical
Alpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors.
Tel Aviv, Israel, November 26, 2019 – Alpha Tau Medical is pleased to announce the publication of the results of its first clinical trial of Alpha DaRT™, a...
September 5, 2018
Proceeds to accelerate expansion of global clinical research program and establish new production facilities to meet growing demand for the company's breakthrough cancer treatment, Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy).
TEL AVIV, Israel, -- Alpha Tau M...
August 22, 2018
CTECH by Calcalist
Alpha Tau is in the last stages of raising an investment of several tens of millions of dollars.
Israeli oncology company Alpha Tau Medical Ltd. is in the last stages of raising an investment of several tens of millions of dollars, one person familiar with the matter to...
May 4, 2018
View article here
July 17, 2017
Following the promising preliminary clinical results, showing the ability of Alpha DaRT to effectively and safely destroy solid tumors, Alpha Tau Medical raises more capital than planned.
Alpha Tau Medical Ltd. has raised 20% more capital than planned for its Alpha DaRT...
In the Media
I'm busy working on my blog posts. Watch this space!